XTL Biopharmaceuticals Ltd. (XTLB) Financials
XTLB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 2.7 million | 162000 |
| 2023-06-30 | 2.9 million | 163000 |
| 2023-03-31 | 3.3 million | 241000 |
| 2022-12-31 | 4.2 million | 187000 |
XTLB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | ? | ? |
| 2023-06-30 | ? | ? |
| 2023-03-31 | ? | ? |
| 2022-12-31 | -2.0 million | 14000 |
XTLB Net Income
No data available :(
XTLB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 2.2 million | - | - |
| 2023-06-30 | 2.4 million | - | - |
| 2023-03-31 | 2.9 million | - | - |
| 2022-12-31 | 3.7 million | - | - |
XTLB Shares Outstanding
XTLB Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 6000 | 145000 | - |
| 2023-06-30 | - | 6000 | 157000 | - |
| 2023-03-31 | - | 13000 | 238000 | - |
| 2022-12-31 | - | 6000 | 219000 | - |
XTLB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | - |
| 2023-06-30 | - | - |
| 2023-03-31 | - | - |
| 2022-12-31 | -459000 | - |
XTLB
Price: $2.60
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.40 USD
P/E Ratio: -2.29
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 5727
Ebitda: -1.4 millionMarket Capitalization: 15.0 million